Diabetes News

A telemedicine-based nutrition counselling program emphasizing a low-carbohydrate diet resulted in sustained diabetes remission over half a decade for some individuals with type 2 diabetes, results of an open-label study showed.

The GLP-1 receptor agonist semaglutide may not only add another therapeutic option for chronic kidney disease, but it could also lead to changes in the way clinicians treat the condition.

CHICAGO — Exenatide, an IV GLP-1 receptor agonist, did not improve clinical outcomes compared with placebo in patients undergoing heart surgery, according to the results of the GLORIOUS trial.

CHICAGO — An intensive blood pressure strategy resulted in a lower incidence of major cardiovascular events compared with a more standard strategy among patients with type 2 diabetes and elevated systolic blood pressure in the BPROAD trial.

Genetic variants found in hidradenitis suppurativa may be correlated to genetic variants in coronary artery disease and diabetes, according to a study.

CHICAGO — An AI-enabled tool utilizing machine learning, high-speed images and video accurately detected hypertension and type 2 diabetes among Japanese adults compared with continuous BP monitoring and HbA1c testing, researchers reported.

Low income corresponded with a higher risk for death among individuals with type 2 diabetes, a South Korean-based cohort analysis published in JAMA Network Open suggested.

Editor’s Note: This is part three of a three-part Healio Exclusive series on the development and use of AI to improve clinical outcomes in cardiovascular medicine and considerations for regulatory labeling and patient privacy .

SAN ANTONIO — A swallowable hydrogel capsule that expands in the stomach demonstrated significant weight-loss, cardiovascular, glycemic and quality of life benefits for patients with overweight or obesity, a speaker reported.